These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37355534)

  • 1. In Vitro and In Vivo Models for Metastatic Intestinal Tumors Using Genotype-Defined Organoids.
    Morita A; Nakayama M; Oshima H; Oshima M
    Methods Mol Biol; 2023; 2691():19-30. PubMed ID: 37355534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent loss of metastatic ability in subclones of Apc, Kras, Tgfbr2, and Trp53 mutant intestinal tumor organoids.
    Morita A; Nakayama M; Wang D; Murakami K; Oshima M
    Cancer Sci; 2023 Apr; 114(4):1437-1450. PubMed ID: 36576236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An In Vivo Metastasis Model Using Genotype-Defined Tumor Organoids.
    Morita A; Nakayama M; Oshima H; Oshima M
    Methods Mol Biol; 2024; 2828():57-68. PubMed ID: 39147970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined Mutation of
    Sakai E; Nakayama M; Oshima H; Kouyama Y; Niida A; Fujii S; Ochiai A; Nakayama KI; Mimori K; Suzuki Y; Hong CP; Ock CY; Kim SJ; Oshima M
    Cancer Res; 2018 Mar; 78(5):1334-1346. PubMed ID: 29282223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR-Cas9-mediated gene knockout in intestinal tumor organoids provides functional validation for colorectal cancer driver genes.
    Takeda H; Kataoka S; Nakayama M; Ali MAE; Oshima H; Yamamoto D; Park JW; Takegami Y; An T; Jenkins NA; Copeland NG; Oshima M
    Proc Natl Acad Sci U S A; 2019 Jul; 116(31):15635-15644. PubMed ID: 31300537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular vesicle release from intestinal organoids is modulated by Apc mutation and other colorectal cancer progression factors.
    Szvicsek Z; Oszvald Á; Szabó L; Sándor GO; Kelemen A; Soós AÁ; Pálóczi K; Harsányi L; Tölgyes T; Dede K; Bursics A; Buzás EI; Zeöld A; Wiener Z
    Cell Mol Life Sci; 2019 Jun; 76(12):2463-2476. PubMed ID: 31028424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and nongenetic mechanisms for colorectal cancer evolution.
    Kok SY; Nakayama M; Morita A; Oshima H; Oshima M
    Cancer Sci; 2023 Sep; 114(9):3478-3486. PubMed ID: 37357016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MET Signaling Mediates Intestinal Crypt-Villus Development, Regeneration, and Adenoma Formation and Is Promoted by Stem Cell CD44 Isoforms.
    Joosten SPJ; Zeilstra J; van Andel H; Mijnals RC; Zaunbrecher J; Duivenvoorden AAM; van de Wetering M; Clevers H; Spaargaren M; Pals ST
    Gastroenterology; 2017 Oct; 153(4):1040-1053.e4. PubMed ID: 28716720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organoid modelling identifies that DACH1 functions as a tumour promoter in colorectal cancer by modulating BMP signalling.
    Hu X; Zhang L; Li Y; Ma X; Dai W; Gao X; Rao X; Fu G; Wang R; Pan M; Guo Q; Xu X; Zhou Y; Gao J; Zhang Z; Cai S; Peng J; Hua G
    EBioMedicine; 2020 Jun; 56():102800. PubMed ID: 32512510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation and analysis of mouse intestinal tumors and organoids harboring APC and K-Ras mutations.
    van Es JH; Clevers H
    Methods Mol Biol; 2015; 1267():125-44. PubMed ID: 25636467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer.
    Xie BY; Wu AW
    Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Colorectal Tumor Organoid Library Demonstrates Progressive Loss of Niche Factor Requirements during Tumorigenesis.
    Fujii M; Shimokawa M; Date S; Takano A; Matano M; Nanki K; Ohta Y; Toshimitsu K; Nakazato Y; Kawasaki K; Uraoka T; Watanabe T; Kanai T; Sato T
    Cell Stem Cell; 2016 Jun; 18(6):827-838. PubMed ID: 27212702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic dissection of colorectal cancer progression by orthotopic transplantation of engineered cancer organoids.
    Fumagalli A; Drost J; Suijkerbuijk SJ; van Boxtel R; de Ligt J; Offerhaus GJ; Begthel H; Beerling E; Tan EH; Sansom OJ; Cuppen E; Clevers H; van Rheenen J
    Proc Natl Acad Sci U S A; 2017 Mar; 114(12):E2357-E2364. PubMed ID: 28270604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RSPO3 expands intestinal stem cell and niche compartments and drives tumorigenesis.
    Hilkens J; Timmer NC; Boer M; Ikink GJ; Schewe M; Sacchetti A; Koppens MAJ; Song JY; Bakker ERM
    Gut; 2017 Jun; 66(6):1095-1105. PubMed ID: 27511199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organoid-based epithelial to mesenchymal transition (OEMT) model: from an intestinal fibrosis perspective.
    Hahn S; Nam MO; Noh JH; Lee DH; Han HW; Kim DH; Hahm KB; Hong SP; Yoo JH; Yoo J
    Sci Rep; 2017 May; 7(1):2435. PubMed ID: 28550311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal cancer progression by mutant p53 through the acquisition of invasiveness associated with complex glandular formation.
    Nakayama M; Sakai E; Echizen K; Yamada Y; Oshima H; Han TS; Ohki R; Fujii S; Ochiai A; Robine S; Voon DC; Tanaka T; Taketo MM; Oshima M
    Oncogene; 2017 Oct; 36(42):5885-5896. PubMed ID: 28628120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific Labeling of Stem Cell Activity in Human Colorectal Organoids Using an ASCL2-Responsive Minigene.
    Oost KC; van Voorthuijsen L; Fumagalli A; Lindeboom RGH; Sprangers J; Omerzu M; Rodriguez-Colman MJ; Heinz MC; Verlaan-Klink I; Maurice MM; Burgering BMT; van Rheenen J; Vermeulen M; Snippert HJG
    Cell Rep; 2018 Feb; 22(6):1600-1614. PubMed ID: 29425513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal carcinogenicity screening of environmental pollutants using organoid-based cell transformation assay.
    Wang Z; Chen S; Guo Y; Zhang R; Zhang Q; Jiang X; Li M; Jiang Y; Ye L; Guo X; Li C; Zhang G; Li D; Chen L; Chen W
    Arch Toxicol; 2024 Jun; 98(6):1937-1951. PubMed ID: 38563870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Organoids to Characterize Signaling Pathways in Cancer Initiation.
    Oatway C; Hirsch CL; Gregorieff A
    Methods Mol Biol; 2018; 1765():315-331. PubMed ID: 29589318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-Derived Organoid Models of Human Neuroendocrine Carcinoma.
    Dijkstra KK; van den Berg JG; Weeber F; van de Haar J; Velds A; Kaing S; Peters DDGC; Eskens FALM; de Groot DA; Tesselaar MET; Voest EE
    Front Endocrinol (Lausanne); 2021; 12():627819. PubMed ID: 33776923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.